DE60219865D1 - Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit - Google Patents
Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse BursalkrankheitInfo
- Publication number
- DE60219865D1 DE60219865D1 DE60219865T DE60219865T DE60219865D1 DE 60219865 D1 DE60219865 D1 DE 60219865D1 DE 60219865 T DE60219865 T DE 60219865T DE 60219865 T DE60219865 T DE 60219865T DE 60219865 D1 DE60219865 D1 DE 60219865D1
- Authority
- DE
- Germany
- Prior art keywords
- herpesvirus
- bursal disease
- infectious bursal
- disease vaccine
- recombinant infectious
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/964,895 US6764684B2 (en) | 2001-09-28 | 2001-09-28 | Avian herpesvirus-based recombinant infectious bursal disease vaccine |
US964895 | 2001-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60219865D1 true DE60219865D1 (de) | 2007-06-14 |
DE60219865T2 DE60219865T2 (de) | 2007-10-25 |
Family
ID=25509131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2002619865 Expired - Lifetime DE60219865T2 (de) | 2001-09-28 | 2002-09-25 | Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit |
Country Status (4)
Country | Link |
---|---|
US (2) | US6764684B2 (de) |
EP (1) | EP1298139B1 (de) |
JP (1) | JP2004000111A (de) |
DE (1) | DE60219865T2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6764684B2 (en) * | 2001-09-28 | 2004-07-20 | Zeon Corporation | Avian herpesvirus-based recombinant infectious bursal disease vaccine |
ES2217967B1 (es) * | 2003-03-31 | 2006-01-01 | Consejo Sup. Investig. Cientificas | Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv. |
ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
ES2307345B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
KR101172921B1 (ko) * | 2004-03-12 | 2012-08-13 | 와이어쓰 엘엘씨 | 감염성 점액낭병 바이러스 항원 분리체 및 백신 |
DE602005003429T2 (de) * | 2004-12-01 | 2008-10-02 | Zeon Corp. | Kodierende DNS für ein Eimeria Apical Membran Antigen 1 und dessen Verwendungen |
ES2310062B1 (es) * | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
JP2008228658A (ja) * | 2007-03-20 | 2008-10-02 | Nippon Zeon Co Ltd | 新規なプロモーター、これを有する組み換え七面鳥ヘルペスウイルス、及びこれを利用した家禽用ワクチン |
US20090246226A1 (en) * | 2008-03-28 | 2009-10-01 | Zeon Corporation | Avian vaccines possessing a positive marker gene |
CA3146727C (en) | 2011-10-21 | 2023-10-31 | Intervet International B.V. | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
EP2768529A1 (de) | 2011-10-21 | 2014-08-27 | Intervet International B.V. | Rekombinanter nichtpathogener mdv-vektor für multivalente immunität |
ES2719409T5 (es) * | 2011-11-30 | 2022-12-07 | Boehringer Ingelheim Animal Health Usa Inc | Vectores recombinantes de Gallid herpesvirus 3 (mdv serotipo 2) que expresan antígenos de patógenos aviares y usos de los mismos |
US9101598B2 (en) | 2011-11-30 | 2015-08-11 | Merial, Inc. | Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof |
US9114108B2 (en) | 2011-11-30 | 2015-08-25 | Merial, Inc. | Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof |
EP2644702A1 (de) | 2012-03-30 | 2013-10-02 | Ceva Sante Animale | Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten |
US10086062B2 (en) | 2012-07-05 | 2018-10-02 | Ohio State Innovation Foundation | Infectious pancreatic necrosis virus (IPNV) vaccine compositions |
EP3608401A1 (de) | 2012-07-05 | 2020-02-12 | Ohio State Innovation Foundation | Zusammensetzungen und verfahren in zusammenhang mit viralen impfstoffen |
EP2845904A1 (de) * | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Rekombinante Hühner-Herpesviren und deren Verwendungen |
AR103245A1 (es) | 2014-12-24 | 2017-04-26 | Intervet Int Bv | Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada |
EP3050572A1 (de) | 2015-01-29 | 2016-08-03 | Ceva Sante Animale | Rekombinante MDV1 und Verwendungen davon |
WO2017216287A1 (en) | 2016-06-17 | 2017-12-21 | Intervet International B.V. | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens |
EP3263129A1 (de) | 2016-06-29 | 2018-01-03 | Ceva Sante Animale | Entenenteritisvirus und verwendungen davon |
CN111542599A (zh) | 2017-10-12 | 2020-08-14 | 英特维特国际股份有限公司 | 编码多种异源抗原的重组非致病性马尔克氏病病毒构建体 |
CN109234315A (zh) * | 2018-09-20 | 2019-01-18 | 青岛易邦生物工程有限公司 | 一种表达传染性法氏囊病毒vp2基因的重组火鸡疱疹病毒株 |
CN114616325A (zh) | 2019-09-11 | 2022-06-10 | 硕腾服务有限责任公司 | 表达禽病原体抗原的重组火鸡疱疹病毒载体和其用途 |
CN110684744A (zh) * | 2019-10-22 | 2020-01-14 | 青岛易邦生物工程有限公司 | 一种表达鸡传染性法氏囊病病毒vp2基因的重组火鸡疱疹病毒株 |
IL299033A (en) | 2020-06-17 | 2023-02-01 | Boehringer Ingelheim Vetmedica Gmbh | Recombinant HVT vectors expressing influenza hemagglutinin and immunogenic compounds, production and uses thereof |
JP2023549787A (ja) | 2020-11-12 | 2023-11-29 | インターベット インターナショナル ベー. フェー. | キメラコロナウイルススパイクタンパク質をコードする組換えベクターおよびその使用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0222842B1 (de) | 1985-05-30 | 1995-05-10 | Commonwealth Scientific And Industrial Research Organisation | Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv) |
US5928648A (en) | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5834305A (en) | 1985-09-06 | 1998-11-10 | Syntro Corporation | Attenuated herpesvirus, herpesvirus which include foreign DNA encoding an amino acid sequence and vaccines containing same |
US5965138A (en) | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
US5961982A (en) | 1985-09-06 | 1999-10-05 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
WO1987004463A1 (en) | 1986-01-27 | 1987-07-30 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
JPH03500601A (ja) | 1987-06-26 | 1991-02-14 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション | ウィルス中和及び保護モノクローナル抗体により認識されるibdv vp2エピトープ |
EP0332677B1 (de) | 1987-07-27 | 1995-07-19 | Syntro Corporation | Attenuierte herpesviren, herpesviren, die für eine aminosäuresequenz kodierende fremde dns beeinhalten und sie enthaltende impfstoffe |
US5595912A (en) | 1990-05-04 | 1997-01-21 | University Of Maryland College Park | Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination |
EP0481072A4 (en) | 1990-05-04 | 1993-06-09 | University Of Maryland At College Park | Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
US5853733A (en) | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
FR2728794B1 (fr) | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
US5626615A (en) * | 1995-05-23 | 1997-05-06 | Activator Methods, Inc. | Chiropractic adjusting instrument |
JPH08322559A (ja) | 1995-06-02 | 1996-12-10 | Chemo Sero Therapeut Res Inst | gB遺伝子プロモーターを用いた組換えヘルペスウイルス |
US6632664B1 (en) | 1997-10-03 | 2003-10-14 | Nippon Zeon Co., Ltd. | Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
US6764684B2 (en) * | 2001-09-28 | 2004-07-20 | Zeon Corporation | Avian herpesvirus-based recombinant infectious bursal disease vaccine |
-
2001
- 2001-09-28 US US09/964,895 patent/US6764684B2/en not_active Expired - Lifetime
-
2002
- 2002-08-29 JP JP2002250040A patent/JP2004000111A/ja active Pending
- 2002-09-25 DE DE2002619865 patent/DE60219865T2/de not_active Expired - Lifetime
- 2002-09-25 EP EP20020021736 patent/EP1298139B1/de not_active Expired - Lifetime
-
2004
- 2004-04-27 US US10/832,353 patent/US7153511B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20030099667A1 (en) | 2003-05-29 |
EP1298139A3 (de) | 2003-09-17 |
US7153511B2 (en) | 2006-12-26 |
DE60219865T2 (de) | 2007-10-25 |
JP2004000111A (ja) | 2004-01-08 |
US6764684B2 (en) | 2004-07-20 |
US20040197351A1 (en) | 2004-10-07 |
EP1298139A2 (de) | 2003-04-02 |
EP1298139B1 (de) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60219865D1 (de) | Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit | |
ATE312624T1 (de) | Impfstoff gegen hpv | |
DK1208214T3 (da) | Genmanipuleret bleb-vaccine | |
HK1077601A1 (zh) | 針對人免疫缺陷病毒的遺傳疫苗 | |
DE69923434D1 (de) | Adjuvierte rekombinante Lebendimpfstoffe gegen Influenza- oder Herpesviren | |
NO20031483D0 (no) | Vaksine | |
DK1427444T3 (da) | West-nil-vaccine | |
AU2002367748A8 (en) | Infectious disease microarray | |
DE60038166D1 (de) | Impfstoff gegen bakterielle antigene | |
DE60223502D1 (de) | Medizinische schlinge | |
NO20024172L (no) | Vaksine | |
EP1603590A4 (de) | Influenza-virus-vakzine | |
NO20033882D0 (no) | Vaksine | |
AU6029000A (en) | Mosaic infectious bursal disease virus vaccines | |
DE60226218D1 (de) | Impfstoff gegen pferdeherpesvirus | |
ATE437656T1 (de) | Impfstoff gegen das maul- und klauensäure-virus | |
IL177903A (en) | Vaccine for Infectious Stock Disease Virus and its Use | |
IL158549A0 (en) | Smallpox vaccine | |
PL372453A1 (en) | An infectious bursal disease virus variant | |
ATE391767T1 (de) | Geflügelkrankheit verursachendes bakterium und daraus stammender impfstoff | |
DE60125927D1 (de) | Impfstoffe gegen hiv | |
DE60322070D1 (de) | Rekombinante bcg-vakzine | |
EP1296710A4 (de) | Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02) | |
DE10290185D2 (de) | Tumorvakzine | |
HUP0002908A2 (en) | Recombinant newcastle disease virus as embryo vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |